Please provide your email address to receive an email when new articles are posted on . The real-world observational study included 293 patients. The lens is designed ...

Please provide your email address to receive an email when new articles are posted on . A study compared the Tecnis PureSee extended depth of focus IOL and a Tecnis ...

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens ...

The TECNIS PureSee™ IOL, recently FDA-approved and recognized with the 2025 MedTech Breakthrough Award for “Best New Technology Solution – Ophthalmology,” is the first and only FDA-approved EDOF IOL ...

Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...